STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer work
LONDON — Novo Nordisk on Monday sought to assure investors that it would regain its momentum in the coming years, outlining plans to expand its pipeline and find new products that it could sell more like consumer goods than traditional medicines…
ImpactNotable 33/100
Why it mattersRule-based estimate: no strong signals; trust 8/10.
RegionsGlobal
Published4 h ago (Mon, 21 Sep 2026 09:33:45 GMT)
RetrievedMon, 21 Sep 2026 12:01:06 GMT via rss
ClassifiedMon, 21 Sep 2026 12:01:12 GMT by heuristic
AuthorAndrew Joseph